On December 27, 2021, Scopus BioPharma Inc. announced that it held its annual general meeting of shareholders on December 20, 2021 and disclosed the preliminary voting results on each of the proposals. According to the preliminary results the shareholders elected Mordechai Saar Hacham and Joshua Levine to the board of the Company. In addition, the Company stated that it will file an amendment to this current report on form 8-K to disclose the final voting results of the annual meeting within 4 business days after receiving First Coast’s final certified report.